Thrive is a digital therapeutic currently under investigation to treat schizophrenia.
Thrive is expected to deliver 24/7, real-time therapy and support targeting the symptoms of schizophrenia, including hallucinations and delusions. Thrive is comprised of a patient-facing application and clinician-facing web interface, and is intended to strengthen the clinician-patient relationship and intended to reinforce the use of clinician-directed pharmacotherapy.
CAUTION: Thrive is an investigational therapeutic device. It is limited by United States law to investigational use. Thrive is not yet available for sale in the United States.